Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease

OBJECTIVES: We have reported increased 2.6-year mortality in clarithromycin- versus placebo-exposed stable coronary heart disease patients, but meta-analysis of randomized trials in coronary heart disease patients showed no significant effect of antibiotics on mortality. Here we report the 6-year mo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gluud, Christian, Als-Nielsen, Bodil, Damgaard, Morten, Fischer Hansen, Jørgen, Hansen, Stig, Helø, Olav H., Hildebrandt, Per, Hilden, Jørgen, Jensen, Gorm Boje, Kastrup, Jens, Kolmos, Hans Jørn, Kjøller, Erik, Lind, Inga, Nielsen, Henrik, Petersen, Lars, Jespersen, Christian M.
פורמט: Artigo
שפה:Inglês
יצא לאור: S. Karger AG 2008
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2820332/
https://ncbi.nlm.nih.gov/pubmed/18451646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000128994
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים